A Careful, Honest Comparison
ChondroFiller® vs
Stem Cell Injection
Both sit under the regenerative-medicine label, but they work differently. ChondroFiller® is a structural scaffold for cartilage formation. Stem cell injections deliver the biological material — cells and signals from bone marrow, adipose tissue or platelet-rich fibrin. Here is the honest comparison.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026Quick Answer
ChondroFiller® is a scaffold; stem cell injections add biological cells and signals. ChondroFiller® places a collagen matrix into a defined cartilage defect so the body’s own cells can rebuild tissue over six to twelve months. Stem cell injections in UK practice typically use bone-marrow aspirate concentrate (BMAC) or fat-derived medicinal signalling cells, injected into the joint to modulate inflammation and support repair. The two are sometimes paired together; at London Cartilage Clinic that combination is delivered as the surgical Liquid Cartilage™ pathway, not as an injection.
The Headline Difference
ChondroFiller® vs Stem Cell Injection — the key difference
A stem cell injection adds cells and signalling factors into the joint environment. ChondroFiller® adds a structural scaffold inside a specific cartilage defect — a matrix that the body’s own cells can migrate into and rebuild over the following six to twelve months. The cleanest way to think about it: ChondroFiller® provides the where and what of new tissue formation; stem cell therapy provides additional who and signal. They address different parts of the same biology.
Mechanism of Action
How each treatment works
ChondroFiller® is a sterile type I/III collagen scaffold injected as a liquid directly into a mapped cartilage defect under ultrasound guidance. It sets into a gel that occupies the defect within minutes.
The patient’s own cells then migrate into the scaffold and lay down new cartilage matrix over six to twelve months. ChondroFiller® is structural and regenerative — it actually fills the defect.
Stem cell injections in UK MSK practice typically use medicinal signalling cells taken from the patient’s own bone marrow (BMAC), fat (adipose-derived) or platelet-rich fibrin. The material is concentrated at the point of care and injected into the joint, usually under ultrasound guidance.
The proposed mechanism is largely paracrine signalling — the cells release factors that modulate inflammation and recruit local cells. They do not by themselves place a structure into a defect.
How Long Results May Last
Duration and number of injections
Tissue formation over 6–12 months
Variable; signal-based, often 12–24 months
Direct duration comparison is misleading: scaffold-based regeneration and signal-based cell therapy are not measured the same way. ChondroFiller® aims for durable structural tissue; most stem cell injection protocols aim primarily for symptom modulation.
Treatment Course
Number of injections
Typically one injection course, with the box quantity (one, two or three) decided from MRI. Single visit. The originally implanted tissue is intended to be durable.
Stem cell injection protocols vary widely. Some clinics offer a single injection; others recommend a series, or annual repeat. Each course involves a fresh harvest from bone marrow, fat or blood, and centre-specific protocols.
Safety and Infection
Safety considerations
Both are outpatient injections with low overall complication rates. ChondroFiller® at London Cartilage Clinic is delivered under real-time ultrasound guidance with full sterile technique and routine IV antibiotic cover; the most serious risk is joint infection, which is rare.
Stem cell injections additionally involve a harvest step (bone marrow aspiration, fat liposuction or blood draw, depending on protocol), each with its own minor risks. UK stem cell therapy is tightly regulated under ATMP and HCT rules; ask any clinic about the regulatory basis of their preparation, the cell source and dose, and what outcome data they publish.
Patient Selection
Who each treatment may suit
ChondroFiller® is for patients with a focal cartilage defect visible on MRI — typically up to around 6 cm² with reasonably preserved surrounding cartilage. It is a defect-targeted treatment. See who is suitable for ChondroFiller?
Stem cell injections are most often recommended for mild-to-moderate joint disease where the goal is modulating the joint environment rather than filling a defined defect, and as a supportive adjunct in some cartilage and soft-tissue protocols.
Patients who want both a scaffold and a stem-cell component in one procedure — for example with a larger defect or a more complex picture — are usually best served by the surgical Liquid Cartilage™ keyhole pathway, where ChondroFiller® and medicinal signalling cells are co-delivered through arthroscopy in a single procedure at a flat £9,800.
Cost and Value
What each treatment costs
At London Cartilage Clinic, ChondroFiller® costs from £3,000 for one box, £5,500 for two and £8,000 for three, all-in. See the ChondroFiller® cost guide.
Stem cell injection prices in the UK vary significantly by clinic, cell source and preparation protocol — commonly £3,000–£8,000 per course, sometimes more for branded protocols. Some clinics quote per session, others per course; ask for the total cost in writing before agreeing.
Where a patient is considering both, the surgical Liquid Cartilage™ pathway at a flat £9,800 is the LCC route that delivers ChondroFiller® and medicinal signalling cells together in a single keyhole procedure. Injection-only ChondroFiller® and injection-only stem cell therapy remain separate, smaller treatments.
Our Honest Take
When we may recommend each
A focal cartilage defect on MRI where a regenerative scaffold can fill the space and support new tissue formation.
A patient who wants a defect-specific regenerative pathway rather than a signal-based joint-environment injection.
Cases where a stem-cell injection alone has already been tried and the underlying defect has not improved.
Mild-to-moderate joint disease where modulating the joint environment is the primary goal rather than filling a defined defect.
A supportive adjunct in some cartilage or soft-tissue protocols, where the treating clinician has planned the role and the timing.
Patients exploring biologic options before committing to a structural procedure such as ChondroFiller® or surgery.
When Each Is The Wrong Answer
When we would not recommend each
Diffuse joint inflammation or early degeneration without a focal cartilage defect — another modality is likely the more appropriate first step.
Active infection or unwillingness to accept the conservative safety protocol.
A patient with a clear focal cartilage defect on MRI, where a scaffold or cell-based implantation procedure is the more direct regenerative step.
Patients expecting a stem cell injection alone to regenerate a defined cartilage defect — the structural evidence for cell injection without a scaffold is less consistent than the symptom-modulation evidence.
Bundled-by-default stem-cell add-on at the time of booking. Combination treatment should be planned at consultation after imaging review, not upsold on the day.
The Bottom Line
In summary
ChondroFiller® and stem cell injections both sit under the regenerative-medicine label, but they work in different ways and answer different clinical questions. Where there is a defined cartilage defect to fill, ChondroFiller® is the more direct regenerative tool; where the goal is modulating the joint environment, stem cell injections may be reasonable. When both a scaffold and a stem-cell component are wanted in one procedure, that is the surgical Liquid Cartilage™ keyhole pathway, not an injection.
ChondroFiller® vs Stem Cell Injection
Frequently asked questions
Are stem cells the same as PRP?
No. PRP concentrates platelets and the growth factors they release; stem cell therapy delivers the cells themselves — usually medicinal signalling cells from bone marrow, fat or platelet-rich fibrin. PRP is a signal-only treatment; stem cell therapy provides cells and signals. They are sometimes used together, but they are not the same product.
Can I have ChondroFiller® with stem cells in the same injection?
At London Cartilage Clinic the combined scaffold-plus-cells pathway is delivered as the surgical Liquid Cartilage™ keyhole procedure at a flat £9,800, not as an injection. We deliberately do not bundle a stem cell injection into the standard ChondroFiller® injection price because the cell component is a separate clinical decision, not a default add-on.
Will a stem cell injection on its own regenerate my cartilage?
The honest answer is: usually not in a structural sense. Stem cell injection protocols have the strongest evidence for symptom modulation and joint-environment effects. The structural regeneration of a defined cartilage defect is harder to demonstrate from cells alone, which is why scaffolds (ChondroFiller®) or cell-based implantation procedures (MACI, ACI) are used when filling a defect is the goal.
How is stem cell therapy regulated in the UK?
UK stem cell therapy for joints sits under ATMP and HCT regulations. Ask any clinic about the regulatory basis of their preparation, the cell source and dose, the handling protocol and what outcome data they publish. A clinic that cannot answer these questions clearly is one to be cautious about.
I had a stem cell injection and it did not help. Will ChondroFiller® work?
That depends on what the imaging shows now. If a focal cartilage defect is the dominant finding, the stem cell injection alone may not have addressed it — ChondroFiller® can be a reasonable next step. We review the post-injection MRI before deciding.
How does the evidence compare?
Stem cell injection evidence is heterogeneous; results depend on the cell source, the preparation and the clinical setting. ChondroFiller® has cartilage-specific outcome data (IKDC, Harris Hip Score, MOCART MRI) and over 19,000 cases of clinical use across joints. See the ChondroFiller® clinical evidence page.
Book a ChondroFiller® Assessment – London
Natural cartilage regeneration starts with the right defect, the right operator, and the right plan.
Learn More about ChondroFiller
Deep dive into our clinical resources and patient guides.
Cost in the UK
ChondroFiller® cost in the UK from £3,000, what is included and why prices vary.
Suitability
Who is suitable for ChondroFiller® as an injection, and who may need caution.
Clinical Evidence
IKDC, Harris Hip Score and MOCART MRI outcomes for ChondroFiller® cartilage regeneration.
Self-Assessment
Five-question ChondroFiller® pathway self-assessment for Prevention, Regeneration, Combination, or Support.
In London
Private ChondroFiller® cartilage repair at our Harley Street clinic.
Liquid Cartilage™ Surgery
Our proprietary keyhole-surgery technique combining ChondroFiller® with MSC co-delivery in a single procedure, for larger or more complex cartilage defects. £9,800.
ChondroFiller vs Arthrosamid
Cartilage regeneration vs joint cushioning, two very different injections.
ChondroFiller vs Hyaluronic Acid
Structural scaffold for cartilage regeneration vs joint-lubricant viscosupplement.
ChondroFiller vs Microfracture
ChondroFiller® regeneration compared to microfracture surgery for cartilage defects.
ChondroFiller vs MACI
ChondroFiller® scaffold compared to matrix-induced autologous chondrocyte implantation.
ChondroFiller vs ACI
ChondroFiller® scaffold compared to the original autologous chondrocyte implantation technique.
ChondroFiller vs PRP
ChondroFiller® cartilage regeneration compared to platelet-rich plasma injection.
ChondroFiller vs Stem Cells
ChondroFiller® compared to stem cell and biologic regenerative treatments.
ChondroFiller vs Knee Replacement
Where ChondroFiller® may help preserve the joint and where replacement is the right answer.
ChondroFiller® Injection
Cartilage Regeneration Overview
ChondroFiller® is a registered trademark of Meidrix Biomedicals GmbH. London Cartilage Clinic is not affiliated with or endorsed by Meidrix Biomedicals.